US 11414379
SPAK kinase inhibitors as neuroprotective agents
granted A61PA61P25/28A61P9/10
Quick answer
US patent 11414379 (SPAK kinase inhibitors as neuroprotective agents) held by United States Government as represented by the Department of Veterans Affairs expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P25/28, A61P9/10